Global Tuberculosis Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Tuberculosis Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Tuberculosis Vaccines Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Immunotherapeutic Vaccines
1.2.3 Booster Vaccines
1.2.4 Others
1.3 Market Segment by Application
1.3.1 Global Tuberculosis Vaccines Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Tuberculosis Vaccines Market Size (2017-2028)
2.1.1 Global Tuberculosis Vaccines Revenue (2017-2028)
2.1.2 Global Tuberculosis Vaccines Sales (2017-2028)
2.2 Global Tuberculosis Vaccines Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Tuberculosis Vaccines Sales by Regions (2017-2022)
2.2.2 Global Tuberculosis Vaccines Revenue by Regions (2017-2022)
2.3 Global Tuberculosis Vaccines Market Size Forecast by Region
2.3.1 Global Tuberculosis Vaccines Sales Forecast by Region (2023-2028)
2.3.2 Global Tuberculosis Vaccines Revenue Forecast by Region (2023-2028)
2.4 Global Top Tuberculosis Vaccines Regions (Countries) Ranking by Market Size
2.5 Tuberculosis Vaccines Market Dynamics
2.5.1 Tuberculosis Vaccines Market Trends
2.5.2 Tuberculosis Vaccines Market Drivers
2.5.3 Tuberculosis Vaccines Market Challenges
2.5.4 Tuberculosis Vaccines Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Tuberculosis Vaccines Manufacturers by Sales (2017-2022)
3.1.1 Global Tuberculosis Vaccines Sales by Manufacturers (2017-2022)
3.1.2 Global Tuberculosis Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Tuberculosis Vaccines Sales in 2021
3.2 Global Top Manufacturers Tuberculosis Vaccines by Revenue
3.2.1 Global Tuberculosis Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Top Tuberculosis Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Tuberculosis Vaccines Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Tuberculosis Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Vaccines as of 2021)
3.4 Global Tuberculosis Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Tuberculosis Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Tuberculosis Vaccines Market
3.7 Key Manufacturers Tuberculosis Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Tuberculosis Vaccines Market Size by Type
4.1 Global Tuberculosis Vaccines Historic Market Review by Type (2017-2022)
4.1.1 Global Tuberculosis Vaccines Sales Market Share by Type (2017-2022)
4.1.2 Global Tuberculosis Vaccines Revenue Market Share by Type (2017-2022)
4.1.3 Tuberculosis Vaccines Price by Type (2017-2022)
4.2 Global Tuberculosis Vaccines Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Tuberculosis Vaccines Sales Forecast by Type (2023-2028)
4.2.2 Global Tuberculosis Vaccines Revenue Forecast by Type (2023-2028)
4.2.3 Tuberculosis Vaccines Price Forecast by Type (2023-2028)
5 Global Tuberculosis Vaccines Market Size by Application
5.1 Global Tuberculosis Vaccines Historic Market Review by Application (2017-2022)
5.1.1 Global Tuberculosis Vaccines Sales Market Share by Application (2017-2022)
5.1.2 Global Tuberculosis Vaccines Revenue Market Share by Application (2017-2022)
5.1.3 Tuberculosis Vaccines Price by Application (2017-2022)
5.2 Global Tuberculosis Vaccines Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Tuberculosis Vaccines Sales Forecast by Application (2023-2028)
5.2.2 Global Tuberculosis Vaccines Revenue Forecast by Application (2023-2028)
5.2.3 Tuberculosis Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Tuberculosis Vaccines Sales Breakdown by Company
6.1.1 North America Tuberculosis Vaccines Sales by Company (2017-2022)
6.1.2 North America Tuberculosis Vaccines Revenue by Company (2017-2022)
6.2 North America Tuberculosis Vaccines Market Size by Type
6.2.1 North America Tuberculosis Vaccines Sales by Type (2017-2028)
6.2.2 North America Tuberculosis Vaccines Revenue by Type (2017-2028)
6.3 North America Tuberculosis Vaccines Market Size by Application
6.3.1 North America Tuberculosis Vaccines Sales by Application (2017-2028)
6.3.2 North America Tuberculosis Vaccines Revenue by Application (2017-2028)
6.4 North America Tuberculosis Vaccines Market Size by Country
6.4.1 North America Tuberculosis Vaccines Sales by Country (2017-2028)
6.4.2 North America Tuberculosis Vaccines Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Tuberculosis Vaccines Sales Breakdown by Company
7.1.1 Europe Tuberculosis Vaccines Sales by Company (2017-2022)
7.1.2 Europe Tuberculosis Vaccines Revenue by Company (2017-2022)
7.2 Europe Tuberculosis Vaccines Market Size by Type
7.2.1 Europe Tuberculosis Vaccines Sales by Type (2017-2028)
7.2.2 Europe Tuberculosis Vaccines Revenue by Type (2017-2028)
7.3 Europe Tuberculosis Vaccines Market Size by Application
7.3.1 Europe Tuberculosis Vaccines Sales by Application (2017-2028)
7.3.2 Europe Tuberculosis Vaccines Revenue by Application (2017-2028)
7.4 Europe Tuberculosis Vaccines Market Size by Country
7.4.1 Europe Tuberculosis Vaccines Sales by Country (2017-2028)
7.4.2 Europe Tuberculosis Vaccines Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Tuberculosis Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Tuberculosis Vaccines Sales by Company (2017-2022)
8.1.2 Asia Pacific Tuberculosis Vaccines Revenue by Company (2017-2022)
8.2 Asia Pacific Tuberculosis Vaccines Market Size by Type
8.2.1 Asia Pacific Tuberculosis Vaccines Sales by Type (2017-2028)
8.2.2 Asia Pacific Tuberculosis Vaccines Revenue by Type (2017-2028)
8.3 Asia Pacific Tuberculosis Vaccines Market Size by Application
8.3.1 Asia Pacific Tuberculosis Vaccines Sales by Application (2017-2028)
8.3.2 Asia Pacific Tuberculosis Vaccines Revenue by Application (2017-2028)
8.4 Asia Pacific Tuberculosis Vaccines Market Size by Region
8.4.1 Asia Pacific Tuberculosis Vaccines Sales by Region
8.4.2 Asia Pacific Tuberculosis Vaccines Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Tuberculosis Vaccines Sales Breakdown by Company
9.1.1 Latin America Tuberculosis Vaccines Sales by Company (2017-2022)
9.1.2 Latin America Tuberculosis Vaccines Revenue by Company (2017-2022)
9.2 Latin America Tuberculosis Vaccines Market Size by Type
9.2.1 Latin America Tuberculosis Vaccines Sales by Type (2017-2028)
9.2.2 Latin America Tuberculosis Vaccines Revenue by Type (2017-2028)
9.3 Latin America Tuberculosis Vaccines Market Size by Application
9.3.1 Latin America Tuberculosis Vaccines Sales by Application (2017-2028)
9.3.2 Latin America Tuberculosis Vaccines Revenue by Application (2017-2028)
9.4 Latin America Tuberculosis Vaccines Market Size by Country
9.4.1 Latin America Tuberculosis Vaccines Sales by Country (2017-2028)
9.4.2 Latin America Tuberculosis Vaccines Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Tuberculosis Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Tuberculosis Vaccines Sales by Company (2017-2022)
10.1.2 Middle East and Africa Tuberculosis Vaccines Revenue by Company (2017-2022)
10.2 Middle East and Africa Tuberculosis Vaccines Market Size by Type
10.2.1 Middle East and Africa Tuberculosis Vaccines Sales by Type (2017-2028)
10.2.2 Middle East and Africa Tuberculosis Vaccines Revenue by Type (2017-2028)
10.3 Middle East and Africa Tuberculosis Vaccines Market Size by Application
10.3.1 Middle East and Africa Tuberculosis Vaccines Sales by Application (2017-2028)
10.3.2 Middle East and Africa Tuberculosis Vaccines Revenue by Application (2017-2028)
10.4 Middle East and Africa Tuberculosis Vaccines Market Size by Country
10.4.1 Middle East and Africa Tuberculosis Vaccines Sales by Country (2017-2028)
10.4.2 Middle East and Africa Tuberculosis Vaccines Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Tuberculosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Sanofi Tuberculosis Vaccines Products and Services
11.1.5 Sanofi Tuberculosis Vaccines SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Tuberculosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Merck Tuberculosis Vaccines Products and Services
11.2.5 Merck Tuberculosis Vaccines SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Serum Institute of India
11.3.1 Serum Institute of India Corporation Information
11.3.2 Serum Institute of India Overview
11.3.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Serum Institute of India Tuberculosis Vaccines Products and Services
11.3.5 Serum Institute of India Tuberculosis Vaccines SWOT Analysis
11.3.6 Serum Institute of India Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 GlaxoSmithKline Tuberculosis Vaccines Products and Services
11.4.5 GlaxoSmithKline Tuberculosis Vaccines SWOT Analysis
11.4.6 GlaxoSmithKline Recent Developments
11.5 Japan BCG Lab
11.5.1 Japan BCG Lab Corporation Information
11.5.2 Japan BCG Lab Overview
11.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Japan BCG Lab Tuberculosis Vaccines Products and Services
11.5.5 Japan BCG Lab Tuberculosis Vaccines SWOT Analysis
11.5.6 Japan BCG Lab Recent Developments
11.6 IDT Biologics
11.6.1 IDT Biologics Corporation Information
11.6.2 IDT Biologics Overview
11.6.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 IDT Biologics Tuberculosis Vaccines Products and Services
11.6.5 IDT Biologics Tuberculosis Vaccines SWOT Analysis
11.6.6 IDT Biologics Recent Developments
11.7 GreenSignal Bio Pharma
11.7.1 GreenSignal Bio Pharma Corporation Information
11.7.2 GreenSignal Bio Pharma Overview
11.7.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 GreenSignal Bio Pharma Tuberculosis Vaccines Products and Services
11.7.5 GreenSignal Bio Pharma Tuberculosis Vaccines SWOT Analysis
11.7.6 GreenSignal Bio Pharma Recent Developments
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Corporation Information
11.8.2 Taj Pharmaceuticals Overview
11.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Taj Pharmaceuticals Tuberculosis Vaccines Products and Services
11.8.5 Taj Pharmaceuticals Tuberculosis Vaccines SWOT Analysis
11.8.6 Taj Pharmaceuticals Recent Developments
11.9 Bavarian Nordic
11.9.1 Bavarian Nordic Corporation Information
11.9.2 Bavarian Nordic Overview
11.9.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Bavarian Nordic Tuberculosis Vaccines Products and Services
11.9.5 Bavarian Nordic Tuberculosis Vaccines SWOT Analysis
11.9.6 Bavarian Nordic Recent Developments
11.10 China National Biotec Group
11.10.1 China National Biotec Group Corporation Information
11.10.2 China National Biotec Group Overview
11.10.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 China National Biotec Group Tuberculosis Vaccines Products and Services
11.10.5 China National Biotec Group Tuberculosis Vaccines SWOT Analysis
11.10.6 China National Biotec Group Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Tuberculosis Vaccines Value Chain Analysis
12.2 Tuberculosis Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tuberculosis Vaccines Production Mode & Process
12.4 Tuberculosis Vaccines Sales and Marketing
12.4.1 Tuberculosis Vaccines Sales Channels
12.4.2 Tuberculosis Vaccines Distributors
12.5 Tuberculosis Vaccines Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Tuberculosis Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Immunotherapeutic Vaccines
Table 3. Major Manufacturers of Booster Vaccines
Table 4. Major Manufacturers of Others
Table 5. Global Tuberculosis Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Tuberculosis Vaccines Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Tuberculosis Vaccines Sales by Region (2017-2022) & (K Doses)
Table 8. Global Tuberculosis Vaccines Sales Market Share by Region (2017-2022)
Table 9. Global Tuberculosis Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Tuberculosis Vaccines Revenue Market Share by Region (2017-2022)
Table 11. Global Tuberculosis Vaccines Sales Forecast by Region (2023-2028) & (K Doses)
Table 12. Global Tuberculosis Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Tuberculosis Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Tuberculosis Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Tuberculosis Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Tuberculosis Vaccines Market Trends
Table 17. Tuberculosis Vaccines Market Drivers
Table 18. Tuberculosis Vaccines Market Challenges
Table 19. Tuberculosis Vaccines Market Restraints
Table 20. Global Tuberculosis Vaccines Sales by Manufacturers (2017-2022) & (K Doses)
Table 21. Global Tuberculosis Vaccines Sales Share by Manufacturers (2017-2022)
Table 22. Global Tuberculosis Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Tuberculosis Vaccines Manufacturers by Revenue (US$ Million) in 2021
Table 24. Tuberculosis Vaccines Revenue Share by Manufacturers (2017-2022)
Table 25. Global Tuberculosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Vaccines as of 2021)
Table 27. Key Manufacturers Tuberculosis Vaccines Average Selling Price (ASP) & (2017-2022) & (USD/Dose)
Table 28. Key Manufacturers Tuberculosis Vaccines Plants/Factories Distribution
Table 29. Key Manufacturers Tuberculosis Vaccines Area Served
Table 30. Date of Key Manufacturers Enter into Tuberculosis Vaccines Market
Table 31. Key Manufacturers Tuberculosis Vaccines Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Tuberculosis Vaccines Sales (K Doses) by Type (2017-2022)
Table 34. Global Tuberculosis Vaccines Sales Share by Type (2017-2022)
Table 35. Global Tuberculosis Vaccines Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Tuberculosis Vaccines Price (K Doses) by Type (2017-2022)
Table 37. Global Tuberculosis Vaccines Sales (K Doses) by Type (2023-2028)
Table 38. Global Tuberculosis Vaccines Sales Share by Type (2023-2028)
Table 39. Global Tuberculosis Vaccines Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Tuberculosis Vaccines Revenue Share by Type (2023-2028)
Table 41. Global Tuberculosis Vaccines Price (K Doses) by Type (2023-2028)
Table 42. Global Tuberculosis Vaccines Sales (K Doses) by Application (2017-2022)
Table 43. Global Tuberculosis Vaccines Sales Share by Application (2017-2022)
Table 44. Global Tuberculosis Vaccines Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Tuberculosis Vaccines Price (K Doses) by Application (2017-2022)
Table 46. Global Tuberculosis Vaccines Sales (K Doses) by Application (2023-2028)
Table 47. Global Tuberculosis Vaccines Sales Share by Application (2023-2028)
Table 48. Global Tuberculosis Vaccines Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Tuberculosis Vaccines Revenue Share by Application (2023-2028)
Table 50. Global Tuberculosis Vaccines Price (K Doses) by Application (2023-2028)
Table 51. North America Tuberculosis Vaccines Sales by Company (2017-2022) & (K Doses)
Table 52. North America Tuberculosis Vaccines Sales Market Share by Company (2017-2022)
Table 53. North America Tuberculosis Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Tuberculosis Vaccines Revenue Market Share by Company (2017-2022)
Table 55. North America Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)
Table 56. North America Tuberculosis Vaccines Sales by Type (2023-2028) & (K Doses)
Table 57. North America Tuberculosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Tuberculosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)
Table 60. North America Tuberculosis Vaccines Sales by Application (2023-2028) & (K Doses)
Table 61. North America Tuberculosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Tuberculosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Tuberculosis Vaccines Sales by Country (2017-2022) & (K Doses)
Table 64. North America Tuberculosis Vaccines Sales by Country (2023-2028) & (K Doses)
Table 65. North America Tuberculosis Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Tuberculosis Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Tuberculosis Vaccines Sales by Company (2017-2022) & (K Doses)
Table 68. Europe Tuberculosis Vaccines Sales Market Share by Company (2017-2022)
Table 69. Europe Tuberculosis Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Tuberculosis Vaccines Revenue Market Share by Company (2017-2022)
Table 71. Europe Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)
Table 72. Europe Tuberculosis Vaccines Sales by Type (2023-2028) & (K Doses)
Table 73. Europe Tuberculosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Tuberculosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)
Table 76. Europe Tuberculosis Vaccines Sales by Application (2023-2028) & (K Doses)
Table 77. Europe Tuberculosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Tuberculosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Tuberculosis Vaccines Sales by Country (2017-2022) & (K Doses)
Table 80. Europe Tuberculosis Vaccines Sales by Country (2023-2028) & (K Doses)
Table 81. Europe Tuberculosis Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Tuberculosis Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Tuberculosis Vaccines Sales by Company (2017-2022) & (K Doses)
Table 84. Asia Pacific Tuberculosis Vaccines Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Tuberculosis Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Tuberculosis Vaccines Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)
Table 88. Asia Pacific Tuberculosis Vaccines Sales by Type (2023-2028) & (K Doses)
Table 89. Asia Pacific Tuberculosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Tuberculosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)
Table 92. Asia Pacific Tuberculosis Vaccines Sales by Application (2023-2028) & (K Doses)
Table 93. Asia Pacific Tuberculosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Tuberculosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Tuberculosis Vaccines Sales by Region (2017-2022) & (K Doses)
Table 96. Asia Pacific Tuberculosis Vaccines Sales by Region (2023-2028) & (K Doses)
Table 97. Asia Pacific Tuberculosis Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Tuberculosis Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Tuberculosis Vaccines Sales by Company (2017-2022) & (K Doses)
Table 100. Latin America Tuberculosis Vaccines Sales Market Share by Company (2017-2022)
Table 101. Latin America Tuberculosis Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Tuberculosis Vaccines Revenue Market Share by Company (2017-2022)
Table 103. Latin America Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)
Table 104. Latin America Tuberculosis Vaccines Sales by Type (2023-2028) & (K Doses)
Table 105. Latin America Tuberculosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Tuberculosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)
Table 108. Latin America Tuberculosis Vaccines Sales by Application (2023-2028) & (K Doses)
Table 109. Latin America Tuberculosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Tuberculosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Tuberculosis Vaccines Sales by Country (2017-2022) & (K Doses)
Table 112. Latin America Tuberculosis Vaccines Sales by Country (2023-2028) & (K Doses)
Table 113. Latin America Tuberculosis Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Tuberculosis Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Tuberculosis Vaccines Sales by Company (2017-2022) & (K Doses)
Table 116. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Tuberculosis Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Tuberculosis Vaccines Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)
Table 120. Middle East and Africa Tuberculosis Vaccines Sales by Type (2023-2028) & (K Doses)
Table 121. Middle East and Africa Tuberculosis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Tuberculosis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)
Table 124. Middle East and Africa Tuberculosis Vaccines Sales by Application (2023-2028) & (K Doses)
Table 125. Middle East and Africa Tuberculosis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Tuberculosis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Tuberculosis Vaccines Sales by Country (2017-2022) & (K Doses)
Table 128. Middle East and Africa Tuberculosis Vaccines Sales by Country (2023-2028) & (K Doses)
Table 129. Middle East and Africa Tuberculosis Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Tuberculosis Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 131. Sanofi Corporation Information
Table 132. Sanofi Description and Overview
Table 133. Sanofi Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 134. Sanofi Tuberculosis Vaccines Product and Services
Table 135. Sanofi Tuberculosis Vaccines SWOT Analysis
Table 136. Sanofi Recent Developments
Table 137. Merck Corporation Information
Table 138. Merck Description and Overview
Table 139. Merck Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 140. Merck Tuberculosis Vaccines Product and Services
Table 141. Merck Tuberculosis Vaccines SWOT Analysis
Table 142. Merck Recent Developments
Table 143. Serum Institute of India Corporation Information
Table 144. Serum Institute of India Description and Overview
Table 145. Serum Institute of India Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 146. Serum Institute of India Tuberculosis Vaccines Product and Services
Table 147. Serum Institute of India Tuberculosis Vaccines SWOT Analysis
Table 148. Serum Institute of India Recent Developments
Table 149. GlaxoSmithKline Corporation Information
Table 150. GlaxoSmithKline Description and Overview
Table 151. GlaxoSmithKline Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 152. GlaxoSmithKline Tuberculosis Vaccines Product and Services
Table 153. GlaxoSmithKline Tuberculosis Vaccines SWOT Analysis
Table 154. GlaxoSmithKline Recent Developments
Table 155. Japan BCG Lab Corporation Information
Table 156. Japan BCG Lab Description and Overview
Table 157. Japan BCG Lab Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 158. Japan BCG Lab Tuberculosis Vaccines Product and Services
Table 159. Japan BCG Lab Tuberculosis Vaccines SWOT Analysis
Table 160. Japan BCG Lab Recent Developments
Table 161. IDT Biologics Corporation Information
Table 162. IDT Biologics Description and Overview
Table 163. IDT Biologics Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 164. IDT Biologics Tuberculosis Vaccines Product and Services
Table 165. IDT Biologics Tuberculosis Vaccines SWOT Analysis
Table 166. IDT Biologics Recent Developments
Table 167. GreenSignal Bio Pharma Corporation Information
Table 168. GreenSignal Bio Pharma Description and Overview
Table 169. GreenSignal Bio Pharma Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 170. GreenSignal Bio Pharma Tuberculosis Vaccines Product and Services
Table 171. GreenSignal Bio Pharma Tuberculosis Vaccines SWOT Analysis
Table 172. GreenSignal Bio Pharma Recent Developments
Table 173. Taj Pharmaceuticals Corporation Information
Table 174. Taj Pharmaceuticals Description and Overview
Table 175. Taj Pharmaceuticals Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 176. Taj Pharmaceuticals Tuberculosis Vaccines Product and Services
Table 177. Taj Pharmaceuticals Tuberculosis Vaccines SWOT Analysis
Table 178. Taj Pharmaceuticals Recent Developments
Table 179. Bavarian Nordic Corporation Information
Table 180. Bavarian Nordic Description and Overview
Table 181. Bavarian Nordic Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 182. Bavarian Nordic Tuberculosis Vaccines Product and Services
Table 183. Bavarian Nordic Tuberculosis Vaccines SWOT Analysis
Table 184. Bavarian Nordic Recent Developments
Table 185. China National Biotec Group Corporation Information
Table 186. China National Biotec Group Description and Overview
Table 187. China National Biotec Group Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 188. China National Biotec Group Tuberculosis Vaccines Product and Services
Table 189. China National Biotec Group Tuberculosis Vaccines SWOT Analysis
Table 190. China National Biotec Group Recent Developments
Table 191. Key Raw Materials Lists
Table 192. Raw Materials Key Suppliers Lists
Table 193. Tuberculosis Vaccines Distributors List
Table 194. Tuberculosis Vaccines Customers List
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Vaccines Product Picture
Figure 2. Global Tuberculosis Vaccines Sales Market Share by Type in 2021 & 2028
Figure 3. Immunotherapeutic Vaccines Product Picture
Figure 4. Booster Vaccines Product Picture
Figure 5. Others Product Picture
Figure 6. Global Tuberculosis Vaccines Sales Market Share by Application in 2021 & 2028
Figure 7. Hospitals Use Case
Figure 8. Clinics Use Case
Figure 9. Others Use Case
Figure 10. Tuberculosis Vaccines Report Years Considered
Figure 11. Global Tuberculosis Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Tuberculosis Vaccines Market Size 2017-2028 (US$ Million)
Figure 13. Global Tuberculosis Vaccines Sales (2017-2022) & (K Doses)
Figure 14. Global Tuberculosis Vaccines Market Size Market Share by Reg

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs